The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- PMID: 32637987
- PMCID: PMC7454352
- DOI: 10.1093/brain/awaa240
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Abstract
Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders. Detailed clinical and paraclinical data were collected from cases where the diagnosis of COVID-19 was confirmed through RNA PCR, or where the diagnosis was probable/possible according to World Health Organization criteria. Of 43 patients, 29 were SARS-CoV-2 PCR positive and definite, eight probable and six possible. Five major categories emerged: (i) encephalopathies (n = 10) with delirium/psychosis and no distinct MRI or CSF abnormalities, and with 9/10 making a full or partial recovery with supportive care only; (ii) inflammatory CNS syndromes (n = 12) including encephalitis (n = 2, para- or post-infectious), acute disseminated encephalomyelitis (n = 9), with haemorrhage in five, necrosis in one, and myelitis in two, and isolated myelitis (n = 1). Of these, 10 were treated with corticosteroids, and three of these patients also received intravenous immunoglobulin; one made a full recovery, 10 of 12 made a partial recovery, and one patient died; (iii) ischaemic strokes (n = 8) associated with a pro-thrombotic state (four with pulmonary thromboembolism), one of whom died; (iv) peripheral neurological disorders (n = 8), seven with Guillain-Barré syndrome, one with brachial plexopathy, six of eight making a partial and ongoing recovery; and (v) five patients with miscellaneous central disorders who did not fit these categories. SARS-CoV-2 infection is associated with a wide spectrum of neurological syndromes affecting the whole neuraxis, including the cerebral vasculature and, in some cases, responding to immunotherapies. The high incidence of acute disseminated encephalomyelitis, particularly with haemorrhagic change, is striking. This complication was not related to the severity of the respiratory COVID-19 disease. Early recognition, investigation and management of COVID-19-related neurological disease is challenging. Further clinical, neuroradiological, biomarker and neuropathological studies are essential to determine the underlying pathobiological mechanisms that will guide treatment. Longitudinal follow-up studies will be necessary to ascertain the long-term neurological and neuropsychological consequences of this pandemic.
Keywords: ADEM; COVID-19; SARS-CoV-2; encephalitis.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
Figures
Comment in
-
Severe COVID-19-related encephalitis can respond to immunotherapy.Brain. 2020 Dec 1;143(12):e102. doi: 10.1093/brain/awaa337. Brain. 2020. PMID: 33064794 Free PMC article. No abstract available.
-
Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?Brain. 2020 Dec 1;143(12):e100. doi: 10.1093/brain/awaa375. Brain. 2020. PMID: 33064796 Free PMC article. No abstract available.
Similar articles
-
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. Rev Neurol (Paris). 2021. PMID: 33446327 Free PMC article. Review.
-
Neurological associations of COVID-19.Lancet Neurol. 2020 Sep;19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0. Epub 2020 Jul 2. Lancet Neurol. 2020. PMID: 32622375 Free PMC article. Review.
-
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18. Lancet Psychiatry. 2020. PMID: 32437679 Free PMC article.
-
The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.J Neurol Sci. 2020 Jul 15;414:116884. doi: 10.1016/j.jns.2020.116884. Epub 2020 May 7. J Neurol Sci. 2020. PMID: 32464367 Free PMC article. Review.
-
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.Trials. 2020 Jul 9;21(1):632. doi: 10.1186/s13063-020-04575-w. Trials. 2020. PMID: 32646502 Free PMC article.
Cited by
-
Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection.Front Immunol. 2024 Oct 4;15:1458231. doi: 10.3389/fimmu.2024.1458231. eCollection 2024. Front Immunol. 2024. PMID: 39430766 Free PMC article.
-
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein.Front Nucl Med. 2022 Nov 23;2:1033697. doi: 10.3389/fnume.2022.1033697. eCollection 2022. Front Nucl Med. 2022. PMID: 39354971 Free PMC article.
-
A Blood Supply Pathophysiological Microcirculatory Mechanism for Long COVID.Life (Basel). 2024 Aug 28;14(9):1076. doi: 10.3390/life14091076. Life (Basel). 2024. PMID: 39337860 Free PMC article.
-
Suspected intracranial hypertension in COVID-19 patients with severe respiratory failure.PLoS One. 2024 Sep 19;19(9):e0310077. doi: 10.1371/journal.pone.0310077. eCollection 2024. PLoS One. 2024. PMID: 39298371 Free PMC article.
-
Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?Curr Microbiol. 2024 Sep 19;81(11):366. doi: 10.1007/s00284-024-03885-5. Curr Microbiol. 2024. PMID: 39297982
References
-
- Absoud M, Lim MJ, Appleton R, Jacob A, Kitley J, Leite MI, et al.Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features. J Neurol Neurosurg Psychiatry 2015; 86: 470–2. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous